We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




HPV Testing to Be More Widely Available Throughout China

By LabMedica International staff writers
Posted on 20 Mar 2012
Free HPV testing will be given to underprivileged women in China, especially in less populated and remote regions.

Qiagen (Hilden, Germany) is expanding access to Human papillomavirus (HPV) screening in China through a comarketing agreement with KingMed Diagnostics (Guangzhou, China), China’s largest independent laboratory network.

The "gold standard" in testing for high-risk types of HPV, the primary cause of cervical cancer, is Qiagen's digene HPV Test

KingMed Diagnostics will function as a centralized lab, allowing smaller hospitals and those in less-populated areas to offer the digene HPV Test and send samples to KingMed Diagnostics for processing and analysis.

The agreement is a landmark for Qiagen’s molecular diagnostics franchise in China and its focus on driving growth in emerging markets. More...
The digene HPV test was first registered in China in 2000 and is now widely available in many of the country’s hospitals and private labs.

Cervical cancer affects approximately 500,000 women annually worldwide and causes about 275,000 deaths each year. After breast cancer, it is the second most common malignancy found in women. In China, there are 80,000-100,000 new cases of cervical cancer each year and 30,000 to 50,000 deaths.

Cervical cancer is caused by high-risk types of HPV. An estimated 80 % of women will get an HPV infection at some point in their lives. However, in most cases, the infection goes away or is suppressed by the body without causing problems. If infections persist abnormal cells are formed, which may develop into cervical cancer if not detected and treated early.

Related Links:

Qiagen
KingMed Diagnostics




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.